In March,2018,Zhejiang Guobang Pharmaceutical Co., Ltd acquired Shaoxing chenyu chemical co., LTD.
In August,2017,Quzhou guoyishanju Health Industry CO.,LTD was founded,China Changshan Health Parl Priject was officially launched;
In March 2017, the Guobang-promoted project of the construction of the Guobang&Chaolonghui Building started.
In February 2017 in Xinchang registered and established Zhejiang Zhong Tong Pharmaceutical Co., Ltd. and passed the pharmaceutical preparation GMP acceptance, marked that the Guobang pharmaceutical industry chain officially entered the field of pharmaceutical preparations;
In December 2016 Group levied the new industrial land in Shandong Weifang, fully open Shandong Guobang Pharmaceutical thousands acres of pharmaceutical industrial park project;
2016 in August Guobang Chemwin Trade Co., Ltd. was established in Hangzhou;
In 2016 June the first party members, workers congress held in Shangyu;
In May 2016 Zhejiang Zhongtong Science and Technology Co., Ltd. the food additives passed the International Religious Food Certification Center SKS certification and access to the Jew (Kosher) food certificate;
In April 2016 Zhejiang Zhongtong Science and Technology Co., Ltd. GBAS project completion and acceptance of polymer materials;
In 2016 Xinchang base was rated as provincial science and technology enterprises;
In 2016 Xinchang base was included in Xinchang County " New Urbanization and New Industrialization" in-depth integration of demonstration enterprises and "digital factory";
In December 2015 Zhejiang Zhongtong Technology Co., Ltd. pharmaceutical semi-preparation, food additives and feed additives construction project completed;
In September 2014, the first Guobang prize was held at the China Pharmaceutical University.
In September 2015 products Enrofloxacin has passed the US FDA's GMP certification;
In September 2015 Xinchang Hebao Biotechnology Co., Ltd. passed the veterinary drug GMP certification for the first time;
In August 2015 Zhejiang Guobang pharmaceutical products clarithromycin passed the Japanese PMDA GMP certification;
In August 2008 Hangzhou Guoyi Industrial Co., Ltd. was established;
During July 30, 2015-August 1, 2015 Guobang Medical Group "2015 annual cadres, science and technology congress" held in Shangyu, officially released "Guobang Enterprise" at the meeting;
In May 2015, year 2011 education students of the Guobang University School completed their studies and smoothly graduated; completed enrollment and formal school for year 2015 students. The students will participate in academic education;
In April 2015 Zhejiang Guobang Pharmaceutical Co., Ltd. products azithromycin passed the Brazilian ANVISA certification;
In December 2014 Zhejiang Guobang pharmaceutical veterinary drug raw materials Marbofloxacin won the national class 2 veterinary drug certificate;
In September 2009 Shandong Guobang buprenorphine and other three products successfully passed the national Ministry of Agriculture veterinary drug GMP acceptance;
In September 2009 Zhejiang Guobang pharmaceutical products such as azithromycin four products passed the EU EUGMP certification;
In March 2013 Zhejiang Guobang Pharmaceutical Co., Ltd. acquired Zhejiang Dongying Pharmaceutical Co., Ltd.;
In December 2012 Zhejiang Guobang pharmaceutical products azelnidipine and Mitiglinide Calcium received class three categories of new drug certificate;
In August 2012, the Group acquired Weifang Yikang Pharmaceutical Chemical Factory and set up Shandong Zhijiang Biotechnology Co., Ltd..
In July 2012 Zhejiang Science and Technology Department approved the establishment of the Guobang Drug Research Institute;
In May 2012, Hangzhou Guobang Enterprise Management Co., Ltd. was established, the group began to enter the capital management, capital operation stage;
In November 2011 Group established Zhejiang Zhongtong Technology Co., Ltd.;
In September 2011 Group acquisition of Shaoxing modern pharmaceutical companies, Zhejiang Guobang Modern Pharmaceutical Co., Ltd. was established, the Group into the field of finished products business;
In July 2009 Zhejiang Guobang pharmaceutical products Fudosteine won the national class three categories of new drug medicine GMP certificate;
In December 2008 Zhejiang Guobang Pharmaceutical Co., Ltd. passed high-tech enterprises certification; then obtained the title of the National Torch Plan focused on high-tech enterprises;
In December 2008 Zhejiang Guobang postdoctoral research station passed the national level certification;
In 2008 June Xinchang Guobang Chemical Industry Co., Ltd. changed to Guobang pharmaceutical and chemical industry group Co., Ltd.;
2008 set up Xinchang Hebao Biological Technology Co., Ltd.
In January 2007, Shandong Guobang Pharmaceutical Co., Ltd. started construction and opened an important step of transnational operation of Guobang enterprises.
In May 2006, the company carried out technical cooperation with Tianjin University to increase the innovation of enterprises.
In April 2006, Zhejiang Guobang Enterprise Education College was established.
September in 2005 Zhejiang Guobang Veterinary Drug Co., Ltd. changed to Zhejiang Guobang Pharmaceutical Co., Ltd.;
In July 2005 Zhejiang Guobang Veterinary Drugs Co., Ltd. staff living area building No.5 and 6 completed, after that building 1 to 4 built;
In October 2004 azithromycin, roxithromycin, ciprofloxacin hydrochloride and other products passed the pharmaceutical GMP certification; clarithromycin, ciprofloxacin lactate, norfloxacin and other products also passed the medical GMP certification;
In September 2003 product deoxyfuridine glycosides passed the national pharmaceutical GMP certification;
In February 2003, products of Zhejiang Guobang veterinary drugs Co., Ltd. Enrofloxacin, ciprofloxacin hydrochloride passes the Ministry of Agriculture veterinary drug GMP certification, Zhejiang Province became the first certified veterinary drug manufacturers; 9 products passed the Ministry of Agriculture veterinary drug GMP certification;
In October 2000 in Zhejiang Shangyu Hangzhou Bay Fine Chemical Park purchased land and started construction, established Zhejiang Guobang Applied Chemical Co., Ltd.; changed to Zhejiang Guobang Veterinary Co., Ltd. later;
In August 2000, the company passed the ISO9002 international certification, and in September 2003 passed ISO9001: 2000 for version certification;
In 1999, developed successfully dalfloxacin side chain; successfully declared two new class of veterinary drugs salafloxacin hydrochloride, made two types of drug certificate, obtained the national key new products and the fund of the Ministry of Science and Technology Innovation Fund.
In 1998, developed and tried the national second category of new veterinary drug grams of beads and its products successfully;
In 1997, completed Enrofloxacin large-scale production of technological transformation tasks successfully, and started the production of ciprofloxacin hydrochloride, pefloxacin mesylate and preparation products series;
In 1995, established Sino-foreign joint ventures - Zhejiang Guobang Feed Co., Ltd., the main products for the feed additive series; has successfully developed Enrofloxacin, tartaric acid, aspartic acid, norfloxacin hydrochloride and more national and provincial level new products;
